Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
30 May 2016 |
Main ID: |
NCT02363673 |
Date of registration:
|
09/02/2015 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
The Effect of Individualised Homoeopathic Treatment of Autism Spectrum Disorder in Children
|
Scientific title:
|
The Effect of Individualised Homoeopathic Treatment of Autism Spectrum Disorder in Children |
Date of first enrolment:
|
February 2015 |
Target sample size:
|
10 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02363673 |
Study type:
|
Interventional |
Study design:
|
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
|
Phase:
|
Phase 2
|
|
Countries of recruitment
|
South Africa
| | | | | | | |
Contacts
|
Name:
|
N Gower, MTechHom |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Senior Lecturer |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- children aged of 3 to 6 years;
- diagnosed with ASD by a physician, psychologist, psychiatrist or neurologist;
- are on no medication or are on medication for ASD and its comorbid conditions for
more than 2 months;
- are able to have their guardian present for all interviews, and
- have mild-to-moderate symptoms ASD as measured using the CARS
Exclusion Criteria:
- a history of or contract organic brain damage, meningitis, epilepsy or encephalitis;
- are on conventional medication such as Fluoxetine, Methylphenidate, Atomoxetine or
Risperidal for less than 2 months or make use of any new medication for ASD or its
comorbid conditions for the duration of the study, or
- currently be taking any herbal or homoeopathic medications.
Age minimum:
3 Years
Age maximum:
6 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Autism Spectrum Disorder
|
Intervention(s)
|
Other: Individualised homoeopathic remedy in aqua distilla
|
Primary Outcome(s)
|
Childhood Autism Rating Scale
[Time Frame: Every 4 weeks for 12 weeks]
|
Secondary Outcome(s)
|
Case notes
[Time Frame: Every 4 weeks for 12 weeks]
|
Autism Treatment Evaluation Checklist
[Time Frame: Every 4 weeks for 12 weeks]
|
Secondary ID(s)
|
CGoodwin201006636
|
REC-01-128-2014
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|